Faculty

Institution

Unit

Venue

Laura Kresty

Medical College of Wisconsin

Affiliations

Medical College of Wisconsin, Research

NoneLaura Kresty is currently serving as a Medical College Of Wisconsin, Research faculty at Medical College of Wisconsin.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Laura Kresty

Medical College of Wisconsin

You can click a keyword to filter the displayed items

cancer research oncology esophageal cancer cancer biology health sciences pharmacology tumor biology medicinal research esophagus cancer care molecular biology medicine esophageal adenocarcinoma carcinogenesis cancer prevention lung cancer molecular cancer cancer treatment cancer genomics nutrition phytotherapy research autophagy cancer management apoptosis hepatology oxidative stress digestive diseases cancer cells enzyme inhibition vascular biology oral cancer cancer risk interferometry cranberry proanthocyanidins antioxidants redox biology cancer letter biomedical imaging disease progression inhibitory activity cancer genetics esophageal tumorigenesis rat esophagus black raspberries plant science medical mycology oncogenes liver cancer clinical mycology oncogenic agent nutrient physiology dietary health nutritional sciences phytochemistry epidemiology of cancer phytopharmacology dietary administration dietary therapy dietary exposure hepatotoxicity nutrient management horticultural science treatment effects chemoprevention strategies food mycology tumor suppressors lyophilized black raspberries brain metastasis mitigates lung tumorigenesis n-nitrosomethylbenzylamine-induced tumorigenesis dietary freeze-dried strawberries dietary ellagic acid esophageal mucosal cytochromes ii enzymes lyophilized berries esophagus patients

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 2988: Patient-Survival Linked Ttll12 Isoform Switching Event Sensitizes Eac Cells to Standard-Of-Care Chemotherapy Agents via Chaperone-Mediated Autophagy. Cancer Research (2025)

Yun ZhangRachel IsraelBryce VandenburgShari BarnettJean-Jack RiethovenJennifer ClarkeMichelle P. LeeDavid A. NtsifulKiran H. LagisettyJules LinRishindra M. ReddyChigozrim EkekeAndrew C. ChangDavid OdellLaura A. Kresty

therapy resistancestandard-of-care chemotherapy agentschaperone-mediated autophagycancer researchautophagymolecular biologyoncologycancer biology

Abstract 550: Identification of Isoform Switching Events Linked With Esophageal Adenocarcinoma Patient Survival Informs Novel Prognostic and Therapeutic Targets. Cancer Research (2024)

Yun ZhangRachel IsraelBryce VandenburgShari BarnettJean-Jack RiethovenJennifer L. ClarkeMichelle P. LeeKiran LagisettyJules LinRishindra ReddyAndrew ChangLaura A. Kresty

cancer careprognosisimmunologymedicinal researchmolecular cancerlung cancercellular therapycancer imagingcancer researchcancer genomicspharmacologycancer managementclinical researchcancer treatmentsurvival analysishealth sciencesoncologycancer biology

Molecular Analysis of Persistent and Recurrent Barrett's Esophagus in the Setting of Endoscopic Therapy. Clinical and Translational Gastroenterology (2024)

Aarti KumarMarianne RaraMing YuKwun Wah WenWilliam M. GradyAmitabh ChakPrasad G. IyerAnil K. RustgiTimothy C. WangJoel H. RubensteinYue LiuLaura KrestyMaria WesterhoffRichard S. KwonErik WamstekerTom WangLynne BerryMarcia I. CantoNicholas J. ShaheenKenneth K. WangJulian A. AbramsMatthew D. Stachler

esophagusclinical gastroenterologygastroenterologymolecular analysismedicineendoscopic therapy

Prebiotic Proanthocyanidins Inhibit Bile Reflux-Induced Esophageal Adenocarcinoma Through Reshaping the Gut Microbiome and Esophageal Metabolome. JCI Insight (2024)

Katherine M WehConnor L HowardYun ZhangBridget A TrippJennifer L ClarkeAmy B HowellJoel H RubensteinJulian A AbramsMaria WesterhoffLaura A Kresty

prebiotic proanthocyanidinsesophageal metabolomegut microbiomepharmacologymicrobiome

Predicting Regression of Barrett’s Esophagus—Can All the King’s Men Put It Together Again?. Biomolecules (2024)

Martin TobiNabiha KhouryOmar Al-SubeeSeema SethiHarvinder TalwarMichael KamJames HatfieldEdi LeviJason HallmanMary Pat MoyerLaura KrestyMichael J. LawsonBenita McVicker

biophysicsesophagusbiomolecular structure predictionbiologybiomanufacturingbiomolecular engineering

451. Isoform Switching Events May Provide New Insight for the Identification of Prognostic and Therapeutic Targets in Esophageal Adenocarcinoma. Diseases of the Esophagus (2023)

Yun ZhangConnor HowardRachel IsraelBryce VandenburgShari BarnettJean-Jack RiethovenJennifer ClarkeKiran LagisettyJules LinRishindra ReddyAndrew ChangLaura A Kresty

immunologypharmacologythoracic oncologyvascular biologyprognosistumor biologygastroenterologycancer researchprognostic biomarkersmedicinal researchdigestive diseasescancer carecancer biologyneurologyesophageal adenocarcinomatumor targetingesophagussurvival analysisoncology

Abstract 1745: Targeting Therapeutic Resistance of Esophageal Adenocarcinoma Through Modulating the Epithelial-To-Mesenchymal Transition via NfκB-Mediated Signaling. Cancer Research (2023)

Yun ZhangKatherine M. WehConnor L. HowardJean-Jack RiethovenJennifer L. ClarkeMichelle P. LeeKiran H. LagisettyJules LinRishindra M. ReddyAndrew C. ChangAmy B. HowellLaura A. Kresty

therapy resistancenfkb-mediated signalingpharmacologythoracic oncologyvascular biologytumor biologyepithelial-to-mesenchymal transitioncancer immunotherapycancer researchmolecular biologycancer treatmenthealth sciencestherapeutic resistancemedicinal researchmolecular cancercancer carecancer biologyesophageal adenocarcinomatumor targetingclinical researchcancer genomicsoncology

Abstract 6141: Mechanisms by Which Mito-Lonidamine Inhibits Egfr Mutant Lung Cancer. Cancer Research (2023)

Katherine M. WehConnor HowardYun ZhangJean-Jack RiethovenJennifer ClarkeGang ChengBalaraman KalyanaramanMing YouLaura Kresty

tumor biologymito-lonidamine inhibitslung cancercancer researchmolecular biologyoncologycancer biology

Abstract Pr001: Mechanisms by Which Mito-Lnd Inhibits Kras Mutant Lung Cancer. Cancer Prevention Research (2023)

Katherine M. WehConnor L. HowardYun ZhangJean-Jack RiethovenJennifer L. ClarkeBalaraman KalyanaramanMing YouLaura A. Kresty

anti-cancer agentsmito-lnd inhibitspharmacologythoracic oncologytumor biologycancer preventionlung cancercancer researchradiation oncologyapoptosismedicinal researchmolecular cancercancer carecancer biologymedicineclinical researchenzyme inhibitioncancer genomicsoncology

Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model. Pharmaceuticals (2023)

Yun ZhangKatherine M. WehBridget A. TrippJennifer L. ClarkeConnor L. HowardShruthi SunilkumarAmy B. HowellLaura A. Kresty

neurologyesophageal adenocarcinoma modelpharmaceutical sciencescranberry proanthocyanidinsmedicinal researchmedicinal chemistryreflux-induced transporter dysregulationtreatment developmentmedicinepharmacologypersonalized medicineoncologypharmaceutical research

1
2
3
4
5
6
7
10 / page

Laura Kresty

Medical College of Wisconsin

Affiliations

Medical College of Wisconsin, Research

NoneLaura Kresty is currently serving as a Medical College Of Wisconsin, Research faculty at Medical College of Wisconsin.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Laura Kresty

Medical College of Wisconsin

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 2988: Patient-Survival Linked Ttll12 Isoform Switching Event Sensitizes Eac Cells to Standard-Of-Care Chemotherapy Agents via Chaperone-Mediated Autophagy. Cancer Research (2025)

therapy resistancestandard-of-care chemotherapy agentschaperone-mediated autophagycancer researchautophagymolecular biologyoncologycancer biology

Abstract 550: Identification of Isoform Switching Events Linked With Esophageal Adenocarcinoma Patient Survival Informs Novel Prognostic and Therapeutic Targets. Cancer Research (2024)

Yun ZhangRachel IsraelBryce VandenburgShari BarnettJean-Jack RiethovenJennifer L. ClarkeMichelle P. LeeKiran LagisettyJules LinRishindra ReddyAndrew ChangLaura A. Kresty

Molecular Analysis of Persistent and Recurrent Barrett's Esophagus in the Setting of Endoscopic Therapy. Clinical and Translational Gastroenterology (2024)

esophagusclinical gastroenterologygastroenterologymolecular analysismedicineendoscopic therapy

Prebiotic Proanthocyanidins Inhibit Bile Reflux-Induced Esophageal Adenocarcinoma Through Reshaping the Gut Microbiome and Esophageal Metabolome. JCI Insight (2024)

Katherine M WehConnor L HowardYun ZhangBridget A TrippJennifer L ClarkeAmy B HowellJoel H RubensteinJulian A AbramsMaria WesterhoffLaura A Kresty

prebiotic proanthocyanidinsesophageal metabolomegut microbiomepharmacologymicrobiome

Predicting Regression of Barrett’s Esophagus—Can All the King’s Men Put It Together Again?. Biomolecules (2024)

Martin TobiNabiha KhouryOmar Al-SubeeSeema SethiHarvinder TalwarMichael KamJames HatfieldEdi LeviJason HallmanMary Pat MoyerLaura KrestyMichael J. LawsonBenita McVicker

biophysicsesophagusbiomolecular structure predictionbiologybiomanufacturingbiomolecular engineering

451. Isoform Switching Events May Provide New Insight for the Identification of Prognostic and Therapeutic Targets in Esophageal Adenocarcinoma. Diseases of the Esophagus (2023)

Yun ZhangConnor HowardRachel IsraelBryce VandenburgShari BarnettJean-Jack RiethovenJennifer ClarkeKiran LagisettyJules LinRishindra ReddyAndrew ChangLaura A Kresty

Abstract 1745: Targeting Therapeutic Resistance of Esophageal Adenocarcinoma Through Modulating the Epithelial-To-Mesenchymal Transition via NfκB-Mediated Signaling. Cancer Research (2023)

Yun ZhangKatherine M. WehConnor L. HowardJean-Jack RiethovenJennifer L. ClarkeMichelle P. LeeKiran H. LagisettyJules LinRishindra M. ReddyAndrew C. ChangAmy B. HowellLaura A. Kresty

Abstract 6141: Mechanisms by Which Mito-Lonidamine Inhibits Egfr Mutant Lung Cancer. Cancer Research (2023)

Katherine M. WehConnor HowardYun ZhangJean-Jack RiethovenJennifer ClarkeGang ChengBalaraman KalyanaramanMing YouLaura Kresty

tumor biologymito-lonidamine inhibitslung cancercancer researchmolecular biologyoncologycancer biology

Abstract Pr001: Mechanisms by Which Mito-Lnd Inhibits Kras Mutant Lung Cancer. Cancer Prevention Research (2023)

Katherine M. WehConnor L. HowardYun ZhangJean-Jack RiethovenJennifer L. ClarkeBalaraman KalyanaramanMing YouLaura A. Kresty

Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model. Pharmaceuticals (2023)

Yun ZhangKatherine M. WehBridget A. TrippJennifer L. ClarkeConnor L. HowardShruthi SunilkumarAmy B. HowellLaura A. Kresty

1
2
3
4
5
6
7
10 / page

Similar Faculty Members

Courtney W. Houchen

Institution

University of Oklahoma

mucosa restitution

pediatrics

Nagireddy Putluri, Ph.D

Institution

Baylor College of Medicine

molecular metabolism

cancer genetics

Raul A. Urrutia, MD

Institution

Medical College of Wisconsin

epigenetics

histone deacetylase

Dhimant Desai

Institution

Pennsylvania State University

future medicinal chemistry

organic chemistry

Karam El-Bayoumy

Institution

Pennsylvania State University

cancer letter

cancer induction

Jennifer Grandis

Institution

University of California, San Francisco

cancer research

oncology

Alexander Zaika

Institution

University of Miami

inflammatory diseases

medicine

Steven M. Dubinett

Institution

University of California, Los Angeles

oncology

cancer research

Wei Li

Institution

University of Tennessee Health Science Center

pharmacology

oncology

Anil Rustgi

Institution

Columbia University

oncology

cancer biology

Similar Faculty Members

Courtney W. Houchen

Institution

University of Oklahoma

mucosa restitution

pediatrics

Nagireddy Putluri, Ph.D

Institution

Baylor College of Medicine

molecular metabolism

cancer genetics

Raul A. Urrutia, MD

Institution

Medical College of Wisconsin

epigenetics

histone deacetylase

Dhimant Desai

Institution

Pennsylvania State University

future medicinal chemistry

organic chemistry

Karam El-Bayoumy

Institution

Pennsylvania State University

cancer letter

cancer induction

Jennifer Grandis

Institution

University of California, San Francisco

cancer research

oncology

Alexander Zaika

Institution

University of Miami

inflammatory diseases

medicine

Steven M. Dubinett

Institution

University of California, Los Angeles

oncology

cancer research

Wei Li

Institution

University of Tennessee Health Science Center

pharmacology

oncology

Anil Rustgi

Institution

Columbia University

oncology

cancer biology